LetsGetChecked
Truepill will operate as a subsidiary of LetsGetChecked, and the acquisition will extend both companies' offerings to cover patients for a longer duration.
Members of the community health network will now have access to LetsGetChecked's suite of offerings via the PatientsLikeMe platform.
Consumers can use the tests to detect Lyme disease, vitamin D levels, thyroid function and sexually transmitted infections.
LetsGetChecked, which closed a $150 million Series D funding round in 2021, made multiple acquisitions this year.
The completed deal comes weeks after LetsGetChecked announced its intent to acquire Veritas Genetics and Veritas Intercontinental.
This acquisition will give LetsGetChecked whole-genome-sequencing capabilities.
LetsGetChecked plans to roll out new care pathways for patients with ailments and chronic conditions.
The startup, which specializes in a range of at-home testing kits, so far only offers a COVID-19 testing product for point-of-care providers.
Also: Ancestory.com cuts 6% of its workforce; NPJ Digital Medicine review outlines challenges holding digital health back.
The New York City-based company will be scaling its brand, expanding its logistics and continuing work on its core technology.